Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial
- DOI
- 10.1136/bmjopen-2024-091495
- Published
- 2025-02
- Container
- BMJ Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2024-091495,
title = {Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial},
author = {Renuka P Dias and Kristian Brock and Kun Hu and Rajat Gupta and Una Martin and Andrew Peet and Martin Wilson and Patrick Yu-Wai-Man and Benjamin Wright and Susan Mollan and Archana Kulkarni and Isabelle Meunier and Lucinda Billingham and Zsuzsanna Nagy and Heather Rose and Sulev Koks and Malgorzata Zatyka and Dewi Astuti and Tracy Lynch and Karen E Morrison and Darren Barton and Sabrina Cronier and Rebecca Malpass and Ruth Evans and Amandip Malhi and Pooja Takhar and Amy Lamb and Gema Esteban-Bueno and Wojciech Młynarski and Christophe Orssaud and Agathe Roubertie and Victoria Homer and Timothy Barrett},
year = {2025},
journal = {BMJ Open},
doi = {10.1136/bmjopen-2024-091495},
url = {https://doi.org/10.1136/bmjopen-2024-091495}
}RIS
TY - JOUR TI - Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial AU - Renuka P Dias AU - Kristian Brock AU - Kun Hu AU - Rajat Gupta AU - Una Martin AU - Andrew Peet AU - Martin Wilson AU - Patrick Yu-Wai-Man AU - Benjamin Wright AU - Susan Mollan AU - Archana Kulkarni AU - Isabelle Meunier AU - Lucinda Billingham AU - Zsuzsanna Nagy AU - Heather Rose AU - Sulev Koks AU - Malgorzata Zatyka AU - Dewi Astuti AU - Tracy Lynch AU - Karen E Morrison AU - Darren Barton AU - Sabrina Cronier AU - Rebecca Malpass AU - Ruth Evans AU - Amandip Malhi AU - Pooja Takhar AU - Amy Lamb AU - Gema Esteban-Bueno AU - Wojciech Młynarski AU - Christophe Orssaud AU - Agathe Roubertie AU - Victoria Homer AU - Timothy Barrett PY - 2025 JO - BMJ Open DO - 10.1136/bmjopen-2024-091495 UR - https://doi.org/10.1136/bmjopen-2024-091495 ER -
APA
Dias, R. P., Brock, K., Hu, K., Gupta, R., Martin, U., Peet, A., Wilson, M., Yu-Wai-Man, P., Wright, B., Mollan, S., Kulkarni, A., Meunier, I., Billingham, L., Nagy, Z., Rose, H., Koks, S., Zatyka, M., Astuti, D., Lynch, T., Morrison, K. E., Barton, D., Cronier, S., Malpass, R., Evans, R., Malhi, A., Takhar, P., Lamb, A., Esteban-Bueno, G., Młynarski, W., Orssaud, C., Roubertie, A., Homer, V., & Barrett, T. (2025). Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2024-091495
Source records
- crossref · retrieved 2026-09-27T00:42:54.563Z